Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

A contradictory role of A1 adenosine receptor in carbon tetrachloride- and bile duct ligation-induced liver fibrosis in mice.

Yang P, Han Z, Chen P, Zhu L, Wang S, Hua Z, Zhang J.

J Pharmacol Exp Ther. 2010 Mar;332(3):747-54. doi: 10.1124/jpet.109.162727. Epub 2009 Dec 10.

2.

Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.

Hubel E, Saroha A, Park WJ, Pewzner-Jung Y, Lavoie EG, Futerman AH, Bruck R, Fishman S, Dranoff JA, Shibolet O, Zvibel I.

Am J Pathol. 2017 Jan;187(1):122-133. doi: 10.1016/j.ajpath.2016.09.005. Epub 2016 Nov 11.

PMID:
27842214
3.

Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.

Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, Schuppan D.

Gastroenterology. 2008 Aug;135(2):660-70. doi: 10.1053/j.gastro.2008.04.009. Epub 2008 Apr 16.

4.

MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.

Yang YL, Wang FS, Li SC, Tiao MM, Huang YH.

Int J Mol Sci. 2017 Jan 18;18(1). pii: E192. doi: 10.3390/ijms18010192.

5.

The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.

Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Osterreicher CH, Kisseleva T, Brenner DA.

Hepatology. 2011 May;53(5):1730-41. doi: 10.1002/hep.24281.

6.

PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.

von Montfort C, Beier JI, Kaiser JP, Guo L, Joshi-Barve S, Pritchard MT, States JC, Arteel GE.

Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G657-66. doi: 10.1152/ajpgi.00107.2009. Epub 2010 Mar 4.

7.

Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.

Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF.

Gastroenterology. 2010 Jan;138(1):347-59. doi: 10.1053/j.gastro.2009.09.015. Epub 2009 Sep 24.

8.

Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.

Takemura T, Yoshida Y, Kiso S, Kizu T, Furuta K, Ezaki H, Hamano M, Egawa M, Chatani N, Kamada Y, Imai Y, Higashiyama S, Iwamoto R, Mekada E, Takehara T.

Biochem Biophys Res Commun. 2013 Jul 26;437(2):185-91. doi: 10.1016/j.bbrc.2013.05.097. Epub 2013 Jun 4.

PMID:
23743191
9.

Matricellular protein periostin contributes to hepatic inflammation and fibrosis.

Huang Y, Liu W, Xiao H, Maitikabili A, Lin Q, Wu T, Huang Z, Liu F, Luo Q, Ouyang G.

Am J Pathol. 2015 Mar;185(3):786-97. doi: 10.1016/j.ajpath.2014.11.002. Epub 2014 Dec 23.

PMID:
25541330
10.

Effectiveness of the PPARγ agonist, GW570, in liver fibrosis.

Yang L, Stimpson SA, Chen L, Wallace Harrington W, Rockey DC.

Inflamm Res. 2010 Dec;59(12):1061-71. doi: 10.1007/s00011-010-0226-0. Epub 2010 Jun 29.

PMID:
20585829
11.

Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.

Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE.

J Pharmacol Exp Ther. 2006 Feb;316(2):592-600. Epub 2005 Oct 12.

12.

Loss of A(1) adenosine receptor attenuates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Yang P, Chen P, Wang T, Zhan Y, Zhou M, Xia L, Cheng R, Guo Y, Zhu L, Zhang J.

Toxicol Sci. 2013 Jan;131(1):128-38. doi: 10.1093/toxsci/kfs263. Epub 2012 Sep 6.

PMID:
22956627
13.

Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, McKeehan WL.

Am J Pathol. 2003 Oct;163(4):1653-62.

14.

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.

Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T.

Hepatology. 2011 Jan;53(1):209-18. doi: 10.1002/hep.23922. Epub 2010 Oct 1.

PMID:
20890893
15.

Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.

Fernández-Martínez E, Pérez-Alvarez V, Tsutsumi V, Shibayama M, Muriel P.

Exp Toxicol Pathol. 2006 Aug;58(1):49-58. Epub 2006 Apr 17.

PMID:
16617007
16.

Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.

Hargrove L, Kennedy L, Demieville J, Jones H, Meng F, DeMorrow S, Karstens W, Madeka T, Greene J Jr, Francis H.

Hepatology. 2017 Jun;65(6):1991-2004. doi: 10.1002/hep.29079. Epub 2017 Apr 28.

PMID:
28120369
17.

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.

Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Lotersztajn S, Prieto J, Berasain C, Avila MA.

Hepatology. 2008 Oct;48(4):1251-61. doi: 10.1002/hep.22437.

PMID:
18634036
18.

c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.

Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.

Gastroenterology. 2009 Jul;137(1):297-308, 308.e1-4. doi: 10.1053/j.gastro.2009.01.068. Epub 2009 Feb 5.

PMID:
19208365
19.

Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.

De Minicis S, Seki E, Paik YH, Osterreicher CH, Kodama Y, Kluwe J, Torozzi L, Miyai K, Benedetti A, Schwabe RF, Brenner DA.

Hepatology. 2010 Oct;52(4):1420-30. doi: 10.1002/hep.23804.

20.

A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.

Teratani T, Tomita K, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Tominaga S, Hiroi S, Irie R, Okada Y, Kurihara C, Ebinuma H, Saito H, Hokari R, Sugiyama K, Kanai T, Miura S, Hibi T.

Gastroenterology. 2012 Jan;142(1):152-164.e10. doi: 10.1053/j.gastro.2011.09.049. Epub 2011 Oct 10.

PMID:
21995947

Supplemental Content

Support Center